Curcumin as an anticancer agent has been reported to induce apoptosis, reduce survival and able to down-regulate Bcl-2, VEGF, cyclin D1, pro-oncogenic factors and NF-κB in colon cancer cells [129,130]. This evidence concerns the gene BCL2 and malignant colon neoplasm.